Triolab´s business operations are expanding
Triolab Oy's business operations are expanding starting April 1, 2025, as the majority of product representations from Immuno Diagnostic Oy, which is part of the same AddLife Group, transfer to Triolab Oy.Read more
Publications about the use of optical genome mapping in clinical research
There are four new key studies proving optical genome mapping (OGM) utility and performance, as a key solution in key clinical research application areas.Read more
Efficiency to diagnosing sepsis
New solutions for sepsis diagnostics have emerged alongside the more conventional methods. As a result, preparing a sepsis diagnosis, identifying the pathogen and determining the antibiotic susceptibility are quicker and more accurate and effective.Read more
Optical genome mapping facilitates the study of genomic structural variation
Human genome has many repeat regions and different structural variations. A new method has been developed for the study of large-scale variation at chromosome level: optical genome mapping.Read more
About different coronavirus assay methods
Several methods have been developed in order to diagnose COVID-19 disease, which is caused by the new coronavirus (SARS-CoV-2). Most methods detect either viral parts or human antibodies from the sample.Read more